Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield
- 1 May 2000
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 40 (5) , 507-512
- https://doi.org/10.1046/j.1537-2995.2000.40050507.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myelomaBone Marrow Transplantation, 1998
- Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex systemBone Marrow Transplantation, 1998
- CD34+ Cell Engraftment, Ex Vivo Expansion, and Malignant Cell Depletion Following Immunomagnetic SelectionJournal of Hematotherapy, 1998
- Circulating CD34-Expressing Cells: German Proficiency Testing SurveyJournal of Hematotherapy, 1998
- Positive Selection and Transplantation of Peripheral CD34+ Progenitor Cells: Feasibility and Purging Efficacy in Pediatric Patients with NeuroblastomaJournal of Hematotherapy, 1997
- Peripheral blood stem cell harvesting and CD34-positive cell selectionPublished by Springer Nature ,1997
- CD34+ Progenitor Cell Selection: Clinical Transplantation, Tumor Cell Purging, Gene Therapy, Ex Vivo Expansion, and Cord Blood ProcessingJournal of Hematotherapy, 1996
- Characterization and Measurement of CD34-Expressing Hematopoietic CellsJournal of Hematotherapy, 1994
- Positive selection of CD34+hematopoietic progenitor cells for transplantationThe International Journal of Cell Cloning, 1993
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993